2007
DOI: 10.1038/nnano.2006.180
|View full text |Cite
|
Sign up to set email alerts
|

Towards an in vivo biologically inspired nanofactory

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
103
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
4
4
2

Relationship

1
9

Authors

Journals

citations
Cited by 163 publications
(103 citation statements)
references
References 36 publications
0
103
0
Order By: Relevance
“…Passively responsive systems capitalizing on anisotropy at both material and structure length scales are finding use in areas such as architecture, where wooden elements are used to open and close in response to humidity fluctuations to achieve building-scale homeostasis 94 . At smaller scales, active biomimetic materials could be used in artificial cells for in vivo travel to targeted sites for drug administration in a non-invasive manner 95 .…”
Section: Future Directionmentioning
confidence: 99%
“…Passively responsive systems capitalizing on anisotropy at both material and structure length scales are finding use in areas such as architecture, where wooden elements are used to open and close in response to humidity fluctuations to achieve building-scale homeostasis 94 . At smaller scales, active biomimetic materials could be used in artificial cells for in vivo travel to targeted sites for drug administration in a non-invasive manner 95 .…”
Section: Future Directionmentioning
confidence: 99%
“…LeDuc et al [33] put forward a lucid vision of such an application, introducingthe concept of a "nanofactory" to be introduced in the body to convert pre-existing materials into therapeutic compounds, or transform molecules that a patient is unable to process, due to some medical condition, into other compounds that the body can process.…”
Section: A Turing Test For Communicating Cellsmentioning
confidence: 99%
“…54 Nanofactories provide novel approaches for in situ drug synthesis and delivery by producing desired materials near target sites. 54 Recently, nanofactories were constructed using polymersomes that allowed the inflow of excess phenylalanine within the nanofactories. The encapsulated phenylalanine ammonia-lyase was able to decrease the level of phenylalanine in vivo.…”
Section: The Shell: Applications Of Artificial Membranes In Biologicamentioning
confidence: 99%